Aussie company scores Trump tariff exemption

Sleep device maker Resmed breathing easy on US tariffs

Sleep device maker Resmed claims it is exempt from US President Donald Trump’s new tariffs as it eyes expansion in the world’s biggest economy.

‘Tariff-exempt’ ResMed boosts US manufacturing

Chief executive Mick Farrell says he’s confident the medical device company’s exports from Australia and Singapore will not be subject to Donald Trump’s levies.

Resmed, the latest company to suggest it won't get hit by tariffs, jumps 9%

ResMed (ASX:RMD) has reported it received an exemption from the current U.S. Administration, meaning it can keep sending its products from Australia and Singapore to the U.S. tariff-free. Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more. Supposedly having been confirmed on April 5, that bombshell hit the market today via ResMed’s latest quarte…

Health Check: Snore-buster Resmed says miracle diet drugs and tariffs no threat to growth

Resmed is unperturbed about the growing use of anti-obesity drugs. which ostensibly will quell demand for its anti-snoring therapies The company also believes it will continue to be subject to zero tariffs in the US, its most important market Resmed reported an 8% rise in March quarter revenue and a 21% earnings surge   Having posted robust third (March) quarter numbers, ResMed (ASX:RMD) CEO Mick Farrell says the two big factors weighing on the …